The identification of 14-3-3 [sigma] as a contributor to cisplatin resistance in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is the predominant type of esophageal cancer in Asia. Cisplatin is commonly used as an agent for treating ESCC patients undergoing chemotherapy. However establishment of resistance over the course of treatment diminishes the clinical usefulness and is one re...
| Main Authors: | , |
|---|---|
| Language: | English |
| Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10722/208627 |